Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
about
Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advancesGlucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismO-GlcNAcylation: a bridge between glucose and cell differentiationO-GlcNAcylation and Metabolic Reprograming in CancerGlcNAcstatins are nanomolar inhibitors of human O -GlcNAcase inducing cellular hyper- O -GlcNAcylationSubstrate and product analogues as human O-GlcNAc transferase inhibitorsHuman OGA binds substrates in a conserved peptide recognition grooveO-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?Regulation of hyaluronan synthesis in vascular diseases and diabetesDiscovery and confirmation of O-GlcNAcylated proteins in rat liver mitochondria by combination of mass spectrometry and immunological methodsDistinct OGT-Binding Sites Promote HCF-1 CleavageGlucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signalingO-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK)Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesisRegulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification.Mucin-type O-glycosylation--putting the pieces together.Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch.The hexosamine signaling pathway: O-GlcNAc cycling in feast or famineO-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stressO-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs.Prkar1a in the regulation of insulin secretion.The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.Uridine affects liver protein glycosylation, insulin signaling, and heme biosynthesis.Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.O-GlcNAc-ylation in the Nuclear Pore Complex.Dynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity.dbOGAP - an integrated bioinformatics resource for protein O-GlcNAcylation.Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteinsIncreased expression of beta-N-acetylglucosaminidase in erythrocytes from individuals with pre-diabetes and diabetes.Power training and postmenopausal hormone therapy affect transcriptional control of specific co-regulated gene clusters in skeletal muscle.O-GlcNAc-mediated interaction between VER2 and TaGRP2 elicits TaVRN1 mRNA accumulation during vernalization in winter wheatO-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease.O-GlcNAc signaling: a metabolic link between diabetes and cancer?Mass spectrometry in the analysis of N-linked and O-linked glycansNatural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation.Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.O-GlcNAc signaling in cancer metabolism and epigeneticsHepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation.
P2860
Q21131281-4E0961EE-A859-4E8F-845E-49E2D19518BCQ21284705-4ED785F4-2FAB-45DA-8E22-177B11F821F5Q26765379-EF28B5DE-9D92-4CEA-86B3-7977C804DFE2Q27027028-48628972-7E4A-4754-BD44-F090357DB579Q27654050-0F8747C8-F25D-4D9A-9DCD-F0A05ABFE68BQ27663568-099EB3D6-D2CA-4C4A-809C-3A9A4FC4AD98Q27664652-5190F030-F5DD-457E-ADC3-EBDA499B46CFQ27693206-AD558F91-4322-4A07-9C40-B24CFEDDB742Q28083625-46E5D0A4-FC5B-4ED1-A70B-978133FBCD44Q28533987-C144291F-4AE3-4930-B89B-D7F5908DD544Q28547471-EAD6D60C-DFF7-47F5-B228-32936E156107Q28581505-C9125361-FBEC-4054-BE2E-F85192A9A6A3Q30368002-D4A82589-4374-428F-BBC7-1316C9725FDDQ30405824-94AA09D9-54A1-43CE-95C7-C05F8BD39D2CQ30436151-4E5A3C38-6FBF-4350-9FC6-FD6FE3627A92Q30490721-33EA9D98-D564-4FEE-ADAC-05B69CC6A15BQ30887465-EFFD5125-38E7-4FDE-9513-52EFCFEDD732Q33411766-8F43923A-7697-47EA-B32C-EFA8581BBC38Q33625053-B4F719A3-AB97-40E1-9273-959A4849BABAQ33625265-52B9B630-7450-4263-A8C2-558017CB9187Q33628891-F4C3A358-A3EE-422E-920D-9A1A658E6341Q33664930-019D72F6-780A-4F43-BDEB-587AE7996692Q33683197-6E95798D-522C-4AD3-B61C-8B23E77FC573Q33740957-707F5652-4138-4EA7-9228-E752807B9418Q33802435-AAFE481A-8AA7-49CF-AC43-54F46B78E81CQ33810805-C8B1278F-7593-4323-8B90-5A40428E4FD2Q33842100-70A7BDBD-28A5-4F6A-A56B-AFFDE746A5C3Q33863321-C13D8D3B-6860-4296-95B8-85D4D5B1AE6BQ33873374-1E662421-AF49-467E-B29F-37F4753F17FDQ33907013-15DDE8CA-5BDF-45C1-9FCC-167D5BEF8892Q33930349-C1B25400-3972-4694-A021-351490161125Q34080414-DB5D9386-328A-4730-B8CE-4A2D9AAD5A40Q34086378-02A9333F-F474-45B6-A834-3FCC853CE9DBQ34101859-70AB10D3-BEA1-463E-818B-6855C225A0C2Q34172895-3FE022E0-DE58-4DCF-9EEE-F3676383F23CQ34247694-B04C8D60-13AE-497F-B8AF-FE390D0B6C7EQ34355572-0E54B418-E057-49B7-9EBA-58B33201CE89Q34357844-3B6A1C6C-D10E-41D2-B567-188AD04BE8C6Q34401725-2C7783F3-FDDA-4D6C-8D8E-C951B25AA3D8Q34442922-481C7EF4-4ADF-4438-9D0A-9A792B763A4B
P2860
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cross-talk between GlcNAcylati ...... sistance and glucose toxicity.
@en
Cross-talk between GlcNAcylati ...... sistance and glucose toxicity.
@nl
type
label
Cross-talk between GlcNAcylati ...... sistance and glucose toxicity.
@en
Cross-talk between GlcNAcylati ...... sistance and glucose toxicity.
@nl
prefLabel
Cross-talk between GlcNAcylati ...... sistance and glucose toxicity.
@en
Cross-talk between GlcNAcylati ...... sistance and glucose toxicity.
@nl
P2093
P2860
P921
P1476
Cross-talk between GlcNAcylati ...... sistance and glucose toxicity.
@en
P2093
Gerald W Hart
John W Bullen
Ronald J Copeland
P2860
P304
P356
10.1152/AJPENDO.90281.2008
P577
2008-04-29T00:00:00Z